Treatment of the protected and unprotected nucleosides with 1,3-dibromo-5,5-dimethylhydantoin in aprotic solvents such as CH 2 Cl 2 , CH 3 CN, or DMF effected smooth bromination of uridine and cytidine derivatives at C-5 of pyrimidine rings as well as adenosine and guanosine derivatives at C-8 of purine rings. Addition of Lewis acids such as trimethylsilyl trifluoromethanesulfonate enhanced the efficiency of bromination.
a b s t r a c t
Treatment of the protected and unprotected nucleosides with 1,3-dibromo-5,5-dimethylhydantoin in aprotic solvents such as CH 2 Cl 2 , CH 3 CN, or DMF effected smooth bromination of uridine and cytidine derivatives at C-5 of pyrimidine rings as well as adenosine and guanosine derivatives at C-8 of purine rings. Addition of Lewis acids such as trimethylsilyl trifluoromethanesulfonate enhanced the efficiency of bromination.
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Halogen-substituted nucleosides and especially uracil derivatives substituted at C-5 and adenine derivatives substituted at C-8 with bromine have been shown to possess interesting synthetic and biological properties. 1, 2 The halogenated C-5 pyrimidine and C-8 purine nucleosides are often used in the reactions involving direct displacement with nucleophiles 1,2 and in transition metal catalyzed cross-coupling reactions 3 resulting in the syntheses of a variety of unnatural nucleosides of biological interest and fluorescent probes. 4 A number of 5-substituted uracil derivatives, especially arabinofuranosyl-and 2 0 -deoxyuridines, have been investigated extensively for the clinical treatment of viral diseases. 5 For instance, the high-yield coupling of 5-iodouracil derivatives with terminal alkynes afforded 5-alkynyluracil nucleosides with antiviral activity 6, 7 and such products can be transformed into furanopyrimidine-2-one derivatives which possess potent and selective inhibition of Varicella-Zoster virus. [21] [22] [23] [24] [25] Enhanced reactivity of DBH toward aromatic bromination in the presence of acids has been noted. [22] [23] [24] Furthermore, Lewis acid-catalyzed benzylic bromination with DBH 26 and efficient oxidation of thiols to disulfides with DBH 27, 28 have been reported. The combination of DBH/TsOH was also used for a-bromination of aliphatic ketones. 29 Herein, we report an efficient bromination of pyrimidine (at C-5 position) and purine (at C-8 position) nucleosides with 1,3-dibromo-5,5-dimethylhydantoin in aprotic solvents and the effect of Lewis acids. Treatment of 2 0 ,3 0 ,5 0 -tri-O-acetyluridine 1a with DBH (1.1 equiv) in CH 2 Cl 2 at ambient temperature for 28 h gave protected 5-bromouridine 2a in 95% yield (Scheme 1; Table 1 , entry 1). Although the DBH reagent can deliver two bromonium equivalents, reaction of 1a with 0.55 equiv of DBH was completed in only 60% yield even after prolonged reaction time (48 h). We found, however, that addition of 0.55 equiv of a Lewis acid such as trimethylsilyl trifluoromethanesulfonate (TMSOTf) significantly enhanced the efficiency of bromination yielding 2a in 94% yield after only 6 h. (entry 2). Bromination of 1a at elevated temperature (40°C) afforded 2a quantitatively in only 2 h (entry 3), while bromination at lower temperature was incomplete even after 8 h and required 1. 
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Tetrahedron Letters j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / t e t l e t TMSOTf to 1.1 equiv had no effect on the rate of reaction (entry 5). Bromination with DBH or the DBH/TMSOTf combination was also effective in polar aprotic solvents such as CH 3 CN and DMF (entries 6-9) providing 2a in shorter reaction times. However, it is noteworthy that bromination in CH 2 Cl 2 provides pure 2a after aqueous workup only and does not require prior evaporation of the solvent from the crude reaction mixture. 30 Moreover, other organic acids such as p-toluenesulfonic acid (TsOH) also efficiently catalyzed the bromination (entry 10). Bromination was much less efficient in protic solvents (e.g., MeOH). The optimized procedure for the 5-bromination of the uracil ring with DBH has general applicability. For example 1-(2,3,5-tri-O-acetyl-b,D-arabinofuranosyl)uracil 1b and 3 0 ,5 0 -di-O-acetyl-2 0 -deoxyuridine 1c were efficiently transformed into 2b 30 and 2c using this approach (Scheme 1; Table 2 , entries 2-6). Furthermore, bromination of the unprotected uridine 1d using DBH in DMF was completed in only 20 min. producing 5-bromouridine 2d in 75% crystallized yield (entry 7). 31 DBH also effected efficient bromination of 1-(b,Darabinofuranosyl)uracil 1e and the acid sensitive 2 0 -deoxyuridine 1f (entries 8 and 9). The 5-bromination of cytidine 3a and 4-N-benzoylcytidine 4a with DBH in DMF proceeded smoothly as well providing 3b and 4b 31 ( Fig. 1 ; Table 3 , entries 1 and 2).
The DBH and DBH/TMSOTf combination also effected bromination of purine nucleosides at the 8 position, although reactions usually required higher equivalency of DBH and longer reaction time. Thus, adenosine 5a and 2 0 -deoxyadenosine 6a afforded 8-bromo products 5b and 6b, albeit in lower isolated yield when compared to the 5-bromination of pyrimidine nucleosides (Table  3, Tables 1 and 2 for specific reaction parameters.
The bromination with DBH is also compatible with common protecting groups used in nucleoside chemistry. Thus, treatment of 5 0 -O-(tert-butyldimethylsilyl)-2 0 ,3 0 -O-isopropylideneuridine 9a with 0.55 equiv of DBH in DMF afforded the corresponding 5-bromo product 9b in quantitative yield (entry 9).
In summary, we have developed an efficient procedure for the bromination of all RNA nucleobases with 1,3-dibromo-5,5-dimethylhydantoin in polar aprotic solvents at ambient temperature with or without the presence of Lewis acids. The method offers a general and convenient procedure for the synthesis of C-5 pyrimidine and C-8 purine brominated nucleosides and 2 0 -deoxynucleosides. The protocol is also compatible with common protecting groups used in nucleoside chemistry. 1 H NMR) with data as reported. Table 3 Bromination of selected purine and pyrimidine nucleosides at ambient temperature (see Fig. 1 
